Most Popular Stories
- GSK, Takeda say nay to in-house diagnostics units
- LEO Pharma slapped with sales-rep overtime suit
- EMC to found Russian cloud computing, 'Big Data' hub
- WellPoint to drop branded Lipitor from its formulary
- Psychologists petition against DSM-5 revisions
- FDA maps out long-awaited rules for the biosimilars business
Webinars
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
Featured Jobs
-
Assistant Director, Reimbursement Strategy and Trends
Xcenda - Charlotte, NC or remote -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Manager, Business Development
Clinical Resource Network - Chicago, IL -
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US
Events
- Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Pharmaceutical Strategic Outlook
April 11-13, 2012 - Euro-Biotech Partnering Summit
May 30-June 1, 2012 — Paris, France - World Orphan Drug Congress USA 2012
10-13 April, 2012 — Gaylord National Resort and Convention Center, Washington, D.C.
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- BRAND-NEW COMPOUNDS
- Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?
- Best Practices: ERP Vendor Reference-Checking
- Pharma is Moving to Digital & Social Media. Wake up!
- Meeting the Unmet Medical Needs and the Training Imperative
- The FDA Review Process: a Technical Look
Republican Congressman W. J. “Billy†Tauzin
Former Republican Congressman W. J. “Billy†Tauzin of Louisiana was named CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) in 2004
